Secondary Logo

Journal Logo

October 2011 - Volume 34 - Issue 5
pp: 443-554


A Phase I Trial of Sorafenib Plus Gemcitabine and Capecitabine for Patients With Advanced Renal Cell Carcinoma: New York Cancer Consortium Trial NCI 6981

Tagawa, Scott T.; Milowsky, Matthew I.; Jeske, Stephanie; More

American Journal of Clinical Oncology. 34(5):443-448, October 2011.


A Phase II Study of Gemcitabine in Combination With Radiation Therapy in Patients With Localized, Unresectable, Pancreatic Cancer: A Hoosier Oncology Group Study

Cardenes, Higinia R.; Moore, Annette M.; Johnson, Cynthia S.; More

American Journal of Clinical Oncology. 34(5):460-465, October 2011.

Comparative Analysis of Outcome in Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria Treated With Liver Transplantation Versus Partial Hepatectomy

Canter, Robert J.; Patel, Siddharth A.; Kennedy, Timothy; More

American Journal of Clinical Oncology. 34(5):466-471, October 2011.

Head & Neck

Metastatic Disease




Soft Tissue


Oncology Economics

ACR Appropriateness Criteria® Postoperative Adjuvant Therapy in Non-Small Cell Lung Cancer

Decker, Roy H.; Langer, Corey J.; Rosenzweig, Kenneth E.; More

American Journal of Clinical Oncology. 34(5):537-544, October 2011.